Ohls, Robin K <br/><br/>
Neurodevelopmental outcome and growth at 18 to 22 months' corrected age in extremely low birth weight infants treated with early erythropoietin and iron.  [electronic resource] 

 -  Pediatrics  Nov 2004 
 - 1287-91 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1098-4275 
<br/><br/><label>Standard No.: </label>10.1542/peds.2003-1129-L  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Blindness--epidemiology<br/>Blood Transfusion--statistics & numerical data<br/>Body Size--drug effects<br/>Cerebral Palsy--epidemiology<br/>Child Development--drug effects<br/>Double-Blind Method<br/>Erythropoietin--pharmacology<br/>Female<br/>Growth--drug effects<br/>Hearing Disorders--epidemiology<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Infant, Premature--growth & development<br/>Infant, Very Low Birth Weight--growth & development<br/>Iron--pharmacology<br/>Male<br/>Psychomotor Disorders--epidemiology